BU-NOT-SET

CONTACT US
A new centre for continuous mRNA manufacturing
  • Biologics
mRNA manufacture
Insight
Unlocking the potential of RNA therapeutics through innovation and collaboration
  • Biologics
RNA
Insight
Using in vitro release testing (IVRT) to analyse semi-solid topical formulations
  • Analytical chemistry
Cream squeezed out of a tube
White paper
Enhancing the production of RNA with continuous manufacturing
  • Biologics
Continuous manufacturing of RNA
Insight
GERTEIS MINI-PACTOR® Advanced dry granulation services
  • Drug product
GERTEIS MINI-PACTOR®
Fact sheet
Overcoming oncolytic virus therapy production challenges through collaboration
  • Biologics
Oncolytic virus therapy production
Case study
Emerging trends set to impact drug development in 2024
  • Industry trends
Trends in drug development
Insight
Webinar: ATMPs in focus: Essential CMC strategies for every phase
  • Biologics
ATMPs in focus
Webinar
Trends set to make an impact on oral solid dose development in 2024
  • Drug product
  • Industry trends
Oral solid dose
Insight
Fact sheet
  • Drug product
Stability studies and analysis for consumer health products
Insight
  • Analytical chemistry
Stability studies are ever changing: Outsourcing as a viable option
Insight
  • Drug substance
Navigating the regulatory landscape for controlled substances
eBook
  • Manufacturing
How to speed up vaccine development and production
Insight
  • Analytical chemistry
Reducing time to market with analytical chemistry
Insight
  • Manufacturing
Serialisation – Looking for value-added opportunities
Insight
  • Analytical chemistry
Outlining the key steps to analytical method development
Insight
  • Drug product
Outsourcing formulation development & manufacturing
Insight
  • Drug product
Complying with Annex 1: Things to bear in mind